• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替代脑脊液性病研究实验室试验用于神经梅毒诊断的方法。

Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.

机构信息

From the Department of Neurology, University of Washington School of Medicine, Seattle, WA.

出版信息

Sex Transm Dis. 2021 Aug 1;48(8S):S54-S57. doi: 10.1097/OLQ.0000000000001450.

DOI:10.1097/OLQ.0000000000001450
PMID:33967236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8514150/
Abstract

BACKGROUND

The diagnosis of neurosyphilis relies in large part on the cerebrospinal fluid (CSF) Venereal Disease Research Laboratory (VDRL) test, which is diagnostically specific but not sensitive.

METHODS

We determined the sensitivity and specificity of 3 CSF tests in addition to the CSF-VDRL in participants with syphilis enrolled in a research study: detection of Treponema pallidum ribosomal RNA, T. pallidum particle agglutination titer, and chemokine (C-X-C motif) ligand 13 (CXCL13) concentration. Neurosyphilis was defined as asymptomatic or symptomatic meningitis: CSF white blood cells >10/μL without or with neurological symptoms, including new vision or hearing loss.

RESULTS

Cerebrospinal fluid-VDRL, CSF T. pallidum ribosomal RNA detection, and CSF T. pallidum particle agglutination titer ≥1:640 were specific (89%-96%) but not sensitive (12%-48%). In contrast, diagnostic sensitivity of CSF-CXCL13 thresholds established from receiver operating characteristic curves using the Youden index was 78% to 83% and specificity was 76% to 81%. In individuals with nonreactive CSF-VDRL, neurosyphilis diagnosis could be confirmed by CSF-CXCL13 concentration in 69% to 75%.

CONCLUSIONS

Further studies of CSF-CXCL13 should include CSF samples from multiple cohorts and countries and should use standard neurosyphilis definitions to establish uniform thresholds for diagnosis.

摘要

背景

神经梅毒的诊断在很大程度上依赖于脑脊液(CSF)性病研究实验室(VDRL)检测,该检测具有诊断特异性,但不敏感。

方法

我们在一项研究中确定了梅毒患者的 3 种 CSF 检测(除了 CSF-VDRL)的敏感性和特异性:检测梅毒核糖体 RNA、梅毒颗粒凝集滴度和趋化因子(C-X-C 基序)配体 13(CXCL13)浓度。神经梅毒定义为无症状或有症状的脑膜炎:CSF 白细胞计数>10/μL 而无或有神经系统症状,包括新的视力或听力损失。

结果

CSF-VDRL、CSF 梅毒核糖体 RNA 检测和 CSF 梅毒颗粒凝集滴度≥1:640 具有特异性(89%-96%)但不敏感(12%-48%)。相比之下,使用约登指数的接收者操作特征曲线建立的 CSF-CXCL13 阈值的诊断敏感性为 78%至 83%,特异性为 76%至 81%。在非反应性 CSF-VDRL 的个体中,CSF-CXCL13 浓度可在 69%至 75%的情况下确认神经梅毒的诊断。

结论

应进一步研究 CSF-CXCL13,包括来自多个队列和国家的 CSF 样本,并应使用标准的神经梅毒定义来建立统一的诊断阈值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b8f/8514150/a917c9edf395/nihms-1744306-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b8f/8514150/a917c9edf395/nihms-1744306-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b8f/8514150/a917c9edf395/nihms-1744306-f0001.jpg

相似文献

1
Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.替代脑脊液性病研究实验室试验用于神经梅毒诊断的方法。
Sex Transm Dis. 2021 Aug 1;48(8S):S54-S57. doi: 10.1097/OLQ.0000000000001450.
2
Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.用于神经梅毒诊断的脑脊液梅毒螺旋体颗粒凝集试验
J Clin Microbiol. 2017 Jun;55(6):1865-1870. doi: 10.1128/JCM.00310-17. Epub 2017 Apr 5.
3
The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.快速血浆反应素试验不能替代性病研究实验室试验用于神经梅毒的诊断。
Sex Transm Dis. 2012 Jun;39(6):453-7. doi: 10.1097/OLQ.0b013e31824b1cde.
4
Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China.中国HIV阴性梅毒患者中脑脊液甲苯胺红不加热血清试验、脑脊液快速血浆反应素试验与脑脊液性病研究实验室试验用于神经梅毒诊断的比较
J Clin Microbiol. 2014 Mar;52(3):736-40. doi: 10.1128/JCM.02522-13. Epub 2013 Dec 11.
5
Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests.非梅毒螺旋体试验在神经梅毒诊断中的应用:性病研究实验室(VDRL)试验和快速血浆反应素环状卡片试验(RPR)评估
J Clin Lab Anal. 2008;22(4):257-61. doi: 10.1002/jcla.20254.
6
Evaluation of treponemal serum tests performed on cerebrospinal fluid for diagnosis of neurosyphilis.评估对脑脊液进行的梅毒螺旋体血清学检测用于诊断神经梅毒的情况。
Am J Clin Pathol. 2015 Apr;143(4):479-84. doi: 10.1309/AJCPWSL3G8RXMCQR.
7
A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis.一种用于神经梅毒诊断的双平台即时检测。
Sex Transm Dis. 2021 May 1;48(5):353-356. doi: 10.1097/OLQ.0000000000001308.
8
Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis.梅毒螺旋体颗粒凝集试验(TP.PA)在神经梅毒诊断中的评估。
J Clin Lab Anal. 2006;20(6):233-8. doi: 10.1002/jcla.20147.
9
Point-of-care treponemal tests for neurosyphilis diagnosis.用于神经梅毒诊断的即时检测梅毒螺旋体试验
Sex Transm Dis. 2015 Jan;42(1):48-52. doi: 10.1097/OLQ.0000000000000222.
10
Criteria for the diagnosis of neurosyphilis in cerebrospinal fluid: relationships with intrathecal immunoglobulin synthesis and blood-cerebrospinal fluid barrier dysfunction.诊断脑脊液神经梅毒的标准:与鞘内免疫球蛋白合成和血脑屏障功能障碍的关系。
Sex Transm Dis. 2013 Dec;40(12):917-22. doi: 10.1097/OLQ.0000000000000049.

引用本文的文献

1
Canadian Public Health Laboratory Network (CPHLN) Diagnostic Recommendations for Neurosyphilis in Canada.加拿大公共卫生实验室网络(CPHLN)关于加拿大神经梅毒的诊断建议。
J Assoc Med Microbiol Infect Dis Can. 2024 Dec 19;9(4):219-228. doi: 10.3138/jammi-2024-0022. eCollection 2024 Dec.
2
Integrated multi-biomarker panel of CXCL13, HS-CRP, and WBC counts predicts outcomes in stroke neurosyphilis patients treated with HBO and TUS-NMES.CXCL13、超敏C反应蛋白(HS-CRP)和白细胞计数的综合多生物标志物组合可预测接受高压氧(HBO)和经颅超声神经肌肉电刺激(TUS-NMES)治疗的中风型神经梅毒患者的预后。
Front Neurol. 2025 Feb 25;16:1530447. doi: 10.3389/fneur.2025.1530447. eCollection 2025.
3
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections.
用于诊断中枢神经系统感染的脑脊液分子诊断学
Clin Microbiol Rev. 2024 Dec 10;37(4):e0002124. doi: 10.1128/cmr.00021-24. Epub 2024 Oct 15.
4
Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.脑脊液 CXCL13 浓度诊断神经梅毒:系统评价和荟萃分析。
BMJ Open. 2024 May 31;14(5):e078527. doi: 10.1136/bmjopen-2023-078527.
5
Comparison of Treponema-specific immunoglobulin G (IgG) index with Treponema pallidum particle agglutination (TPPA) index for detection of intrathecal Treponema-specific antibody synthesis for serological diagnosis of neurosyphilis.比较梅毒螺旋体特异性免疫球蛋白G(IgG)指数与梅毒螺旋体颗粒凝集试验(TPPA)指数用于检测鞘内梅毒螺旋体特异性抗体合成以进行神经梅毒的血清学诊断。
GMS Infect Dis. 2023 Aug 17;11:Doc01. doi: 10.3205/id000081. eCollection 2023.
6
Performance of the nontreponemal tests and treponemal tests on cerebrospinal fluid for the diagnosis of neurosyphilis: A meta-analysis.非梅毒螺旋体试验和梅毒螺旋体试验在诊断神经梅毒中的脑脊液表现:一项荟萃分析。
Front Public Health. 2023 Feb 2;11:1105847. doi: 10.3389/fpubh.2023.1105847. eCollection 2023.
7
An Updated Review of Recent Advances in Neurosyphilis.神经梅毒近期进展的最新综述
Front Med (Lausanne). 2022 Sep 20;9:800383. doi: 10.3389/fmed.2022.800383. eCollection 2022.
8
Intrathecal Synthesis Index of Specific Anti- IgG: a New Tool for the Diagnosis of Neurosyphilis.鞘内合成指数特异性抗 IgG:神经梅毒诊断的新工具。
Microbiol Spectr. 2022 Feb 23;10(1):e0147721. doi: 10.1128/spectrum.01477-21. Epub 2022 Feb 9.